- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/58 - Radicals substituted by nitrogen atoms
Patent holdings for IPC class C07D 317/58
Total number of patents in this class: 267
10-year publication summary
|
17
|
14
|
8
|
6
|
7
|
18
|
37
|
40
|
16
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Terran Biosciences, Inc. | 107 |
17 |
| Empathbio, Inc. | 27 |
14 |
| Enveric Biosciences Canada Inc. | 65 |
12 |
| Anji Pharmaceuticals Inc. | 31 |
8 |
| Alexander Shulgin Research Institute, Inc. | 28 |
7 |
| Transcend Therapeutics, Inc. | 29 |
6 |
| Janssen Pharmaceutica N.V. | 3168 |
5 |
| Immunomet Therapeutics Inc. | 31 |
5 |
| H. Lundbeck A/S | 1232 |
5 |
| Cybin IRL Limited | 69 |
5 |
| Centre National de La Recherche Scientifique | 11023 |
4 |
| Curza Global, LLC | 28 |
4 |
| The Scripps Research Institute | 1344 |
4 |
| University of Utah Research Foundation | 1862 |
4 |
| Arcadia Medicine, Inc. | 9 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
3 |
| Takeda Pharmaceutical Company Limited | 2712 |
3 |
| Memorial Sloan-Kettering Cancer Center | 2043 |
3 |
| Sunovion Pharmaceuticals Inc. | 244 |
3 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3304 |
3 |
| Other owners | 148 |